The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
The first human glucagon-like peptide-1 analog (liraglutide) was registered in Russia in May 2010. This review contains data on the results of randomizedclinical studies of this preparation applied to the treatment of patients with DM2 as monotherapy and in combination with traditional hypoglycemica...
| 1. Verfasser: | |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Endocrinology Research Centre
2010-09-01
|
| Schriftenreihe: | Сахарный диабет |
| Schlagworte: | |
| Online Zugang: | https://www.dia-endojournals.ru/jour/article/view/5497 |